Skip to main content

Table 2 Patient and tumour characteristics

From: Multidisciplinary first-day consultation accelerates diagnostic procedures and throughput times of patients in a head-and-neck cancer care pathway, a mixed method study

  Pre-MFDC Post-MFDC Sign.
2007 (n = 21) 2008 (n = 20) 2010 (n = 24) 2013 (n = 24) ANOVA
Age Mean(SD) 66 (11) 66 (13) 63 (13) 64 (9) .640
  Chi2
Gender n % n % n % n % .680
 Male 14 67 13 65 18 75 14 58  
Tumour localization .303
 Lip 0 0 0 0 0 0 2 100  
 Oral cavity 8 38 11 55 17 71 9 38  
  Tongue (C01, C02) 3   2   6   1   
  Gums (C03) 1   3   2   0   
  Floor of mouth (C04) 3   4   4   6   
  Oral cavity, unspec. 1   2   5   2   
(C00, C05, C06, C14)
 Major salivary glands (C07, C08) 1 5 0 0 0 0 0 0  
 Oropharynx (C09,C10) 2 10 2 10 1 4 4 17  
 Nasopharynx (C11) 1 5 2 10 1 4 1 4  
 Nasal Cavity (C30) 0   0 0 1 4 1 4  
 Hypopharynx (C12, C13) 3 14 1 5 0 0 5 21  
 Larynx (C32) 6 29 4 20 4 17 2 8  
Tumour size .522
 T1 9 43 8 40 10 42 4 17  
 T2 5 24 4 20 5 21 6 26  
 T3 3 14 2 10 3 13 2 8  
 T4 4 19 6 30 5 21 12 50  
 Tx 0 0 0 0 1 0 0 0  
  1. In bold main patient characteristics of the dataset (age, gender, tumour localization and size)